⌘K
Loading ticker…
Liquidia Corporation Common Stock · Healthcare · Pharmaceutical Products
As of 2026-06-26, Liquidia Corporation Common Stock (LQDA) has a 3-month relative strength percentile of 97 and a leadership percentile of 99 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 96. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 6.9%, relative volume 1.45×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
3m RS is 97, Market Stance is mixed at 47, A/D rating A
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
LQDA is in a stage 2 uptrend, week 10. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: 40.4% / 105.3%.
No attention data for this ticker yet — it joins the daily scan once a baseline builds.
LQDA is held by 6 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $79M notional. Top 3 carry $168M.
Top 6 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $79M |
| IWMiShares Russell 2000 ETF | 0.08% | $60M |
| VXFVanguard Extended Market ETF | 0.04% | $29M |
| IWOiShares Russell 2000 Growth ETF | 0.17% | $20M |
| XPHState Street SPDR S&P Pharmaceuticals ETF | 1.88% | $6M |
| ITOTiShares Core S&P Total U.S. Stock Market ETF | 0.00% | $3M |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | LQDA Jan avg: 13.44% median: 13.62% win: 100% σ: 9.92% n: 4 2022-04-12 → 2026-05-29 | LQDA Feb avg: 1.88% median: 9.83% win: 75% σ: 19.29% n: 4 2022-04-12 → 2026-05-29 | LQDA Mar avg: 3.08% median: -0.30% win: 50% σ: 13.51% n: 4 2022-04-12 → 2026-05-29 | LQDA Apr avg: -6.16% median: -5.29% win: 20% σ: 7.31% n: 5 2022-04-12 → 2026-05-29 | LQDA May avg: 12.07% median: 6.80% win: 80% σ: 30.58% n: 5 2022-04-12 → 2026-05-29 | LQDA Jun avg: -4.80% median: -5.04% win: 25% σ: 9.85% n: 4 2022-04-12 → 2026-05-29 (current) | LQDA Jul avg: 15.07% median: 5.96% win: 50% σ: 24.16% n: 4 2022-04-12 → 2026-05-29 | LQDA Aug avg: 8.61% median: 3.31% win: 50% σ: 30.88% n: 4 2022-04-12 → 2026-05-29 | LQDA Sep avg: -6.53% median: -6.72% win: 25% σ: 9.43% n: 4 2022-04-12 → 2026-05-29 | LQDA Oct avg: 2.05% median: 4.90% win: 75% σ: 8.48% n: 4 2022-04-12 → 2026-05-29 | LQDA Nov avg: 13.26% median: 8.22% win: 100% σ: 14.11% n: 4 2022-04-12 → 2026-05-29 | LQDA Dec avg: 25.61% median: 16.30% win: 100% σ: 30.34% n: 4 2022-04-12 → 2026-05-29 |